CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Midazolam

咪达唑仑 杂质对照品Midazolam Impurities

EP44 个杂质条目44 impurity entries

本页汇总 咪达唑仑 的 44 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 44 impurity reference standards of Midazolam with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 咪达唑仑(Midazolam)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSynthesis of the impurities during the manufacture of bulk drug midazolam and separation of these impurities by HPLC
    Acta pharmaceutica (Zagreb, Croatia) · 2013 · Sati B et al.  ·  PMID 24152898  ·  DOI
  2. 杂质研究Impurity studiesCharacterization of degradation products of midazolam maleate by UHPLC-HR-IT-MS(n) and NMR
    Die Pharmazie · 2017 · Feng X et al.  ·  PMID 29441856  ·  DOI
  3. 杂质研究Impurity studiesBenefits of methylated cyclodextrins in the development of midazolam pharmaceutical formulations
    Journal of pharmaceutical sciences · 2013 · Mathiron D et al.  ·  PMID 23609010  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and validation of a method using supported liquid extraction for the simultaneous determination of midazolam and 1'-hydroxy-midazolam in human plasma by liquid chromatography with tandem mass spectrometry detection
    Journal of pharmaceutical and biomedical analysis · 2012 · Svanström C et al.  ·  PMID 21993197  ·  DOI
  5. 分析方法Analytical MethodsValidation of a new HPLC method for determination of midazolam and its metabolites: application to determine its pharmacokinetics in human and measure hepatic CYP3A activity in rabbits
    Journal of pharmaceutical and biomedical analysis · 2009 · Elbarbry F et al.  ·  PMID 19664894  ·  DOI

咪达唑仑 —— 原料药与杂质对照品Midazolam — drug substance & impurities

共 44 个条目(含原料药本体)44 items incl. the drug substance
Midazolam Impurity 1 (Midazolam EP Impurity A) structure
EPA
咪达唑仑杂质1 (咪达唑仑EP杂质A)Midazolam Impurity 1 (Midazolam EP Impurity A)
Midazolam Impurity 1 (Midazolam EP Impurity A)
CAS No.59468-07-4
Chemical FormulaC18H15ClFN3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 2 (Midazolam EP Impurity B) structure
EPB
咪达唑仑杂质2 (咪达唑仑EP杂质B)Midazolam Impurity 2 (Midazolam EP Impurity B)
Midazolam Impurity 2 (Midazolam EP Impurity B)
CAS No.59469-74-8
Chemical FormulaC18H13ClFN3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 3 (Midazolam EP Impurity C) structure
EPC
咪达唑仑杂质3 (咪达唑仑EP杂质C)Midazolam Impurity 3 (Midazolam EP Impurity C)
Midazolam Impurity 3 (Midazolam EP Impurity C)
CAS No.59468-44-9
Chemical FormulaC19H13ClFN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 4 (Midazolam EP Impurity D) structure
EPD
咪达唑仑杂质4 (咪达唑仑EP杂质D)Midazolam Impurity 4 (Midazolam EP Impurity D)
Midazolam Impurity 4 (Midazolam EP Impurity D)
CAS No.59468-83-6
Chemical FormulaC18H13ClFN3O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 5 (Midazolam EP Impurity E) structure
EPE
咪达唑仑杂质5 (咪达唑仑EP杂质E)Midazolam Impurity 5 (Midazolam EP Impurity E)
Midazolam Impurity 5 (Midazolam EP Impurity E)
CAS No.59467-64-0
Chemical FormulaC16H15ClFN3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 5 Maleate(Midazolam EP Impurity E Maleate) structure
EPE
咪达唑仑杂质5 马来酸盐(咪达唑仑EP杂质E 马来酸盐)Midazolam Impurity 5 Maleate(Midazolam EP Impurity E Maleate)
Midazolam Impurity 5 Maleate(Midazolam EP Impurity E Maleate)
CAS No.59469-29-3
Chemical FormulaC16H15ClFN3·2(C4H4O4)
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 6 (Midazolam EP Impurity F) structure
EPF
咪达唑仑杂质6 (咪达唑仑EP杂质F)Midazolam Impurity 6 (Midazolam EP Impurity F)
Midazolam Impurity 6 (Midazolam EP Impurity F)
CAS No.2886-65-9
Chemical FormulaC15H10ClFN2O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 7 (Midazolam EP Impurity G) structure
EPG
咪达唑仑杂质7 (咪达唑仑EP杂质G)Midazolam Impurity 7 (Midazolam EP Impurity G)
Midazolam Impurity 7 (Midazolam EP Impurity G)
CAS No.59467-86-6
Chemical FormulaC18H14ClN3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 8 (Midazolam EP Impurity H) structure
EPH
咪达唑仑杂质8 (咪达唑仑EP杂质H)Midazolam Impurity 8 (Midazolam EP Impurity H)
Midazolam Impurity 8 (Midazolam EP Impurity H)
CAS No.119401-13-7
Chemical FormulaC15H10ClFN2
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 9 (Midazolam EP Impurity I) structure
EPI
咪达唑仑杂质9 (咪达唑仑EP杂质I)Midazolam Impurity 9 (Midazolam EP Impurity I)
Midazolam Impurity 9 (Midazolam EP Impurity I)
CAS No.59467-69-5
Chemical FormulaC18H15ClFN3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 10(Midazolam EP Impurity J) structure
EPJ
咪达唑仑杂质10(咪达唑仑EP杂质J)Midazolam Impurity 10(Midazolam EP Impurity J)
Midazolam Impurity 10(Midazolam EP Impurity J)
CAS No.59469-08-8
Chemical FormulaC18H17ClFN3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 11 structure
11
咪达唑仑杂质11Midazolam Impurity 11
Midazolam Impurity 11
CAS No.60656-76-0
Chemical FormulaC16H11ClFN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 12 structure
12
咪达唑仑杂质12Midazolam Impurity 12
Midazolam Impurity 12
CAS No.59468-90-5
Chemical FormulaC18H13ClFN3O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 13 structure
13
咪达唑仑杂质13Midazolam Impurity 13
Midazolam Impurity 13
CAS No.59468-85-8
Chemical FormulaC18H13ClFN3O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 15 structure
15
咪达唑仑杂质15Midazolam Impurity 15
Midazolam Impurity 15
CAS No.59468-73-4
Chemical FormulaC18H15ClFN3O·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 17 structure
17
咪达唑仑杂质17Midazolam Impurity 17
Midazolam Impurity 17
CAS No.2454678-38-5
Chemical FormulaC18H12ClFN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 19 structure
19
咪达唑仑杂质19Midazolam Impurity 19
Midazolam Impurity 19
CAS No.7142-09-8
Chemical FormulaC9H7ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 24 structure
24
咪达唑仑杂质24Midazolam Impurity 24
Midazolam Impurity 24
CAS No.2531288-23-8
Chemical FormulaC22H17ClFN3O4
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 25 structure
25
咪达唑仑杂质25Midazolam Impurity 25
Midazolam Impurity 25
CAS No.201602-89-3
Chemical FormulaC16H15ClFN3O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 27 structure
27
咪达唑仑杂质27Midazolam Impurity 27
Midazolam Impurity 27
CAS No.205877-01-6
Chemical FormulaC15H13ClFNS2
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 29 structure
29
咪达唑仑杂质29Midazolam Impurity 29
Midazolam Impurity 29
CAS No.59468-72-3
Chemical FormulaC18H14ClFN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 32 structure
32
咪达唑仑杂质32Midazolam Impurity 32
Midazolam Impurity 32
CAS No.151921-06-1
Chemical FormulaC18H12ClFN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 33 structure
33
咪达唑仑杂质33Midazolam Impurity 33
Midazolam Impurity 33
CAS No.2766571-10-0
Chemical FormulaC16H13ClFN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 36 structure
36
咪达唑仑杂质36Midazolam Impurity 36
Midazolam Impurity 36
CAS No.1099229-51-2
Chemical FormulaC16H11ClFN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 37 structure
37
咪达唑仑杂质37Midazolam Impurity 37
Midazolam Impurity 37
CAS No.59469-12-4
Chemical FormulaC23H15ClFN3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 38 structure
38
咪达唑仑杂质38Midazolam Impurity 38
Midazolam Impurity 38
CAS No.138729-68-7
Chemical FormulaC16H16ClN3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 39 structure
39
咪达唑仑杂质39Midazolam Impurity 39
Midazolam Impurity 39
CAS No.59467-63-9
Chemical FormulaC16H11ClFN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 40 structure
40
咪达唑仑杂质40Midazolam Impurity 40
Midazolam Impurity 40
CAS No.59467-61-7
Chemical FormulaC16H13ClFN3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 41 (N-Nitroso Midazolam Impurity 40) structure
41
咪达唑仑杂质41 (N-亚硝基托咪达唑仑杂质40)Midazolam Impurity 41 (N-Nitroso Midazolam Impurity 40)
Midazolam Impurity 41 (N-Nitroso Midazolam Impurity 40)
CAS No.59467-62-8
Chemical FormulaC16H12ClFN4O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 43 structure
43
咪达唑仑杂质43Midazolam Impurity 43
Midazolam Impurity 43
CAS No.105470-75-5
Chemical FormulaC18H15BrN4
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 45 structure
45
咪达唑仑杂质45Midazolam Impurity 45
Midazolam Impurity 45
CAS No.28910-83-0
Chemical FormulaC13H8ClF2NO
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 46 structure
46
咪达唑仑杂质46Midazolam Impurity 46
Midazolam Impurity 46
CAS No.59469-31-7
Chemical FormulaC16H16FN3
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 47 structure
47
咪达唑仑杂质47Midazolam Impurity 47
Midazolam Impurity 47
CAS No.1033824-50-8
Chemical FormulaC24H21ClFN3O6
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 48 structure
48
咪达唑仑杂质48Midazolam Impurity 48
Midazolam Impurity 48
CAS No.2454678-37-4
Chemical FormulaC20H17ClFN3O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 49 structure
49
咪达唑仑杂质49Midazolam Impurity 49
Midazolam Impurity 49
CAS No.60656-72-6
Chemical FormulaC15H11Cl2FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 50 structure
50
咪达唑仑杂质50Midazolam Impurity 50
Midazolam Impurity 50
CAS No.60656-74-8
Chemical FormulaC15H9Cl2FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 51 structure
51
咪达唑仑杂质51Midazolam Impurity 51
Midazolam Impurity 51
CAS No.81256-81-7
Chemical FormulaC24H21ClFN3O7
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 52 structure
52
咪达唑仑杂质52Midazolam Impurity 52
Midazolam Impurity 52
CAS No.160954-14-3
Chemical FormulaC15H9Cl2FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 55 structure
55
咪达唑仑杂质55Midazolam Impurity 55
Midazolam Impurity 55
CAS No.5219-86-3
Chemical FormulaC15H10ClFN2O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 61 structure
61
咪达唑仑杂质61Midazolam Impurity 61
Midazolam Impurity 61
CAS No.872729-00-5
Chemical FormulaC16H13ClFN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 64 structure
64
咪达唑仑杂质64Midazolam Impurity 64
Midazolam Impurity 64
CAS No.64740-64-3
Chemical FormulaC16H13ClFN3O
Purity>95%询价On request
10mg25mg50mg100mg
Midazolam Impurity 12-d4 structure
12-D4
咪达唑仑杂质12-d4Midazolam Impurity 12-d4
Midazolam Impurity 12-d4
CAS No.1781843-10-4
Chemical FormulaC18H9D4ClFN3O
Purity>95%询价On request
Midazolam Impurity 12-d5 structure
12-D5
咪达唑仑杂质12-d5Midazolam Impurity 12-d5
Midazolam Impurity 12-d5
CAS No.1276651-09-2
Chemical FormulaC18H8D5ClFN3O
Purity>95%询价On request
Midazolam Impurity 12-13C6 structure
12-13C6
咪达唑仑杂质12-13C6Midazolam Impurity 12-13C6
Midazolam Impurity 12-13C6
CAS No.1261396-36-4
Chemical FormulaC1213C6H13ClFN3O
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

咪达唑仑 —— 研究文献与合成路线Midazolam — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 咪达唑仑 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Midazolam. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. The 60-day temperature-dependent degradation of midazolam and Lorazepam in the prehospital environment
    McMullan JT, Pinnawin A, Jones E, et al. · Prehospital emergency care · 2013 · 被引 22cited 22
  2. Characterization of degradation products of midazolam maleate by UHPLC-HR-IT-MSn and NMR
    Feng X, Du G, Hou T, et al. · Die Pharmazie · 2017 · 被引 3cited 3
  3. Synthesis of the impurities during the manufacture of bulk drug midazolam and separation of these impurities by HPLC
    Sati B, Sati H, Saklani S, et al. · Acta pharmaceutica (Zagreb, Croatia) · 2013 · 被引 1cited 1
  4. Development and validation of a rapid and sensitive assay for simultaneous quantification of midazolam, 1'-hydroxymidazolam, and 4-hydroxymidazolam by liquid chromatography coupled to tandem mass-spectrometry
    Dostalek M, Macwan JS, Chitnis SD, et al. · Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2010 · 被引 15cited 15
  5. Spectrophotometric determination of midazolam in pharmaceutical formulations
    Pfendt LB, Popović GV, Supancić SI · Journal of pharmaceutical and biomedical analysis · 1995 · 被引 2cited 2

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE SYNTHESIS OF 4H-IMIDAZO [1,5-a] [1,4] BENZODIAZEPINES, IN PARTICULAR MIDAZOLAM AND SALTS THEREOF
    CASTELLIN ANDREA, MAGGINI MICHELE, DONNOLA PAOLA · 公开号 US2011275799US2011275799 · 2011
  2. Process for the synthesis of 4H-imidazo[1,5-a][1,4]benzodiazepines, in particular midazolam and salts thereof
    CASTELLIN ANDREA, MAGGINI MICHELE, DONNOLA PAOLA · 公开号 EP2397470EP2397470 · 2011
  3. PROCESS FOR PRODUCING HIGHLY PURE MIDAZOLAM AND SALTS THEREOF
    KRIVONOS SONIA, SERY YANA · 公开号 US2009069306US2009069306 · 2009
  4. PROCESS FOR THE PREPARATION OF MIDAZOLAM
    DHAON MADHUP K · 公开号 EP1265901EP1265901 · 2002
  5. PROCESS FOR THE PREPARATION OF MIDAZOLAM
    DHAON MADHUP K · 公开号 WO0170744WO0170744 · 2001

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

咪达唑仑 杂质谱研究要点Midazolam — impurity profiling notes

下面这些是拿到 咪达唑仑 的 44 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 44 impurity entries for Midazolam, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances